Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.790
-0.090 (-1.84%)
At close: May 30, 2025, 4:00 PM
4.610
-0.180 (-3.76%)
After-hours: May 30, 2025, 7:25 PM EDT

Radiopharm Theranostics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
May '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
36122426-
Market Cap Growth
73.79%-50.78%-10.18%--
Enterprise Value
121084-
PS Ratio
176.168.935.74--
PB Ratio
1.120.640.780.61-
P/TBV Ratio
11.20--5.56-
EV/Sales Ratio
57.808.022.04--
Debt / Equity Ratio
-----0.47
Asset Turnover
0.000.030.08--
Quick Ratio
3.251.111.223.430.21
Current Ratio
3.371.301.233.460.21
Return on Equity (ROE)
-112.21%-131.49%-63.78%-96.82%-
Return on Assets (ROA)
-28.95%-30.04%-22.57%-29.86%-
Return on Capital (ROIC)
-59.05%-60.55%-32.93%-39.60%-
Earnings Yield
-73.83%-274.09%-97.15%-79.40%-
FCF Yield
-59.63%-131.34%-65.25%-25.86%-
Buyback Yield / Dilution
-243.78%-26.36%-68.74%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q